DHI
48
4
ALL
37
2
NWS
62
4
MSFT
46
2
COF
60
3
NVDA
55
4
KMI
69
4
SJM
19
5
AMZN
61
2
PWR
66
7
AA
47
4
CA
16
3
CPB
30
5
ECL
57
3
ALLE
44
5
HPQ
53
3
BDX
41
3
AFL
41
4
XYL
35
4
CNP
44
5
DHI
48
4
ALL
37
2
NWS
62
4
MSFT
46
2
COF
60
3
NVDA
55
4
KMI
69
4
SJM
19
5
AMZN
61
2
PWR
66
7
AA
47
4
CA
16
3
CPB
30
5
ECL
57
3
ALLE
44
5
HPQ
53
3
BDX
41
3
AFL
41
4
XYL
35
4
CNP
44
5
Financhill
Back

Novo Nordisk AS Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
36

NVO
Novo Nordisk AS

Last Price:
110.04
Seasonality Move:
7.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Novo Nordisk AS Price Quote

$110.04
-0.09 (0.29%)
(Updated: November 6, 2024 at 3:55 AM ET)

Novo Nordisk AS Key Stats

Sell
36
Novo Nordisk AS (NVO) is a Sell
Day range:
$107.75 - $110.30
52-week range:
$94.73 - $148.15
Dividend yield:
1.31%
P/E ratio:
40.74
P/S ratio:
13.17
P/B ratio:
30.34%
Volume:
6.4M
Avg. volume:
5M
1-year change:
12.18%
Market cap:
$490.1B
Revenue:
$33.7B
EPS:
$2.91

How Much Does Novo Nordisk AS Make?

Is Novo Nordisk AS Growing As A Company?

  • What Is Novo Nordisk AS's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.24%
  • What Is Novo Nordisk AS's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.03%

Novo Nordisk AS Stock Price Performance

  • Did Novo Nordisk AS Stock Go Up Last Month?
    Novo Nordisk AS share price went down by -4.33% last month
  • Did NVO's Share Price Rise Over The Last Year?
    NVO share price rose by 12.18% over the past 1 year

What Is Novo Nordisk AS 52-Week High & Low?

Novo Nordisk AS Price To Free Cash Flow

Is It Risky To Buy Novo Nordisk AS?

  • How Much Debt Does Novo Nordisk AS Have?
    Total long term debt quarterly is $8.2B
  • How Much Cash Does Novo Nordisk AS Have?
    Cash and short term investments quarterly total is $9B
  • What Is Novo Nordisk AS’s Book Value Per Share?
    Book value per share is 3.63

Is Novo Nordisk AS Cash Flow Positive?

  • What Is NVO Cash Flow From Operations?
    Cash flow from operations (TTM) is $16.6B
  • What Is Novo Nordisk AS’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.7B
  • What Is Novo Nordisk AS’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.5B

Novo Nordisk AS Return On Invested Capital

  • Is Management Doing A Good Job?
    NVO return on invested capital is 68.37%
  • What Is Novo Nordisk AS Return On Assets?
    ROA measures how assets are converting to revenues and is 28.81%
  • What Is NVO Return On Equity?
    ROE is a measure of profitability and is 89.79%

Novo Nordisk AS Earnings Date & Stock Price

Novo Nordisk AS Competitors

  • Who Are Novo Nordisk AS's Competitors?
    Below is a list of companies who compete with Novo Nordisk AS or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Amgen Inc (AMGN)
    • Evaxion Biotech AS (EVAX)
    • Genfit SA (GNFT)
    • Viking Therapeutics Inc (VKTX)

Novo Nordisk AS Dividend Yield

Novo Nordisk AS Analyst Estimates

YoY Growth Past Surprise
EPS: 2.65% -7.7%
Revenue: 23.79% -0.96%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 2
Price Target: 136.11
Upside from Last Price: 23.59%

Major Shareholders

  • How many NVO shares are owned by institutional investors?
    447.9M NVO shares are owned by institutional investors
  • How many NVO shares are owned by insiders?
    0 NVO shares are owned by insiders